Neuralstem (CUR) – FDA
-
Neuralstem (CUR) Reports Last Subject Enrollment in Ph. 2 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke Patients
-
Neuralstem (CUR) Reports Publication of Results from Phase 1 Clinical Trial Evaluating NSI-566
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CUR Stock Lookup